daratumumab · Medicine question

How long should women of childbearing potential use effective contraception during and after daratumumab treatment?

Name: How long should women of childbearing potential use effective contraception during and after daratumumab treatment?
Published: 2026-11-08T01:43:12.097Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Women of childbearing potential should use effective contraception throughout daratumumab treatment and for 3 months after treatment stops.

Sources for this answer

DARZALEX 20 mg/mL concentrate for solution for infusionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 34Document updated 30 March 2026

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about daratumumab